Novo Nordisk has implemented a global hiring freeze covering job roles that are not critical for its business, Reuters writes ...

Novo Nordisk surges as Wegovy secures FDA approval for MASH, marking a breakthrough in liver care and expanding its blockbuster reach.

GoodRx is joining the GLP-1 action with an announcement Monday to begin selling both Novo Nordisk's GLP-1 drugs, Ozempic and Wegovy, at a cash price of $499 per month.

Tools like Claimable and Fight Health Insurance use AI to guide people through the insurance appeals process and generate ...

Longer-term studies will be needed to track whether per-patient costs might drop over time with continued use of the meds.

GoodRx (GDRX) is joining in on the GLP-1 action with an announcement on Monday that it will begin selling both of Novo Nordisk's (NVO) GLP-1 drugs, Ozempic for diabetes and Wegovy for weight loss, at ...

Eli Lilly and Company’s LLY stock has declined 5.1% so far this month, despite announcing strong second-quarter results on Aug. 7. The company beat estimates for both earnings and sales. Sales of ...

Last year, GLP-1s dominated many employer conversations as demand surged and pressure mounted from employees clamoring for ...